DNAJC2 p.Asp523Gly
c.1568A>G · VCV4243242
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2601 | likely benign |
|---|---|---|
| REVEL | 0.185 | benign-leaning |
| SaProt | LLR -10.27 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense and REVEL do not. | ||
| Splicing | ||
| SpliceAI | — | not looked up on this page · why |
| Constraint at this position | ||
| Conservation | phyloP 7.9 | GERP 0.59, phastCons 1 |
| Regional constraint | o/e 0.90 | unconstrained · MANE · 7,271 bp · p 0.069 · regional, not allelic |
| Overall | ||
| CADD | 25.6 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.0453% | 2,207 |
| Remaining individualsnot grpmax-eligible | 0.0048% | 20,834 |
| Finnishnot grpmax-eligible | 0.00312% | 32,003 |
| European (non-Finnish) | 0.00161% | 62,096 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- DNAJC2
- Protein
- p.Asp523Gly
- Coding
- c.1568A>G
- MANE Select
- NM_004279 · reported on NM_014377
- Type
- single nucleotide variant
- Location
- chr7:103315832 (GRCh38)
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dnajc2-p-asp523gly (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown